i.dahlberg
Submits third-party assay reports on material purchased directly. Based in Accra.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.39%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041760 | Selank | TFS | TFS-{CAT}-1712 | Janoshik | 2026-Q2 | 99.82 | 7.70 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043302 | Retatrutide | CPC | CPC-2604-H1694 | PeptideMeter | 2026-Q2 | 96.54 | 3.77 | 102.2 | Buyer-sourced | 0 | PASS |
| AX-2026-042143 | PT-141 (Bremelanotide) | JEEP | JEEP-2601-K8195 | PeptideMeter | 2026-Q2 | 98.46 | 4.65 | 93.8 | Buyer-sourced | 1 | FAIL |
| AX-2025-020043 | L-Glutathione (reduced) | SWB | SWB-2506-B7923 | PeptideMeter | 2025-Q4 | 99.39 | 10.59 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019631 | BPC-157 | TFC | TFC-2507-J2316 | Janoshik | 2025-Q3 | 98.85 | 4.11 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020953 | Liraglutide | WXT | WXT-2504-L3444 | Janoshik | 2025-Q3 | 97.45 | 5.96 | — | Supplier-supplied | 0 | FAIL |
| AX-2025-021180 | SS-31 (Elamipretide) | PPG | PPG-2411-D6795 | PeptideMeter | 2025-Q1 | 99.93 | 5.09 | 106.2 | Supplier-supplied | 0 | PASS |
| AX-2024-004629 | SS-31 (Elamipretide) | TFC | TFC-2410-F1982 | PeptideMeter | 2024-Q4 | 99.40 | 5.77 | 91.5 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004869 | Ipamorelin | ERP | ERP-2406-F9295 | Nordanalyt | 2024-Q3 | 99.59 | 4.62 | 88.6 | Buyer-sourced | 1 | MARGINAL |